WeVote
Log In

Bill

Bill

SF 46

A bill for an act relating to the licensure of medical cannabidiol dispensaries.

2025-2026 Regular Session Introduced by Scott Webster

Bill SF 46 increases medical cannabidiol dispensary licenses from five to ten, enhancing patient access and creating more business opportunities in the cannabis sector.

Committee report approving bill, renumbered as SF 399.
#drugs #marijuana #professionallicensure
0
WeVote Research Nonpartisan
Bill Summary · SF 46

Summary of Bill SF 46: Licensure of Medical Cannabidiol Dispensaries

Bill Number: SF 46
Title: A bill for an act relating to the licensure of medical cannabidiol dispensaries
Status: Committee report approving bill, renumbered as SF 399
Introduced: January 15, 2025
Classification: Bill
Subject: Drugs, Marijuana, Professional Licensure

Purpose and Intent

The primary purpose of Bill SF 46 is to amend existing regulations regarding the licensure of medical cannabidiol dispensaries in the state. The bill aims to expand access to medical cannabidiol by increasing the number of dispensary licenses available, thereby enhancing the availability of medical cannabis products for patients in need.

Key Provisions

  1. Increase in Licenses:

    • The bill increases the maximum number of medical cannabidiol dispensary licenses from five to ten. This change is intended to facilitate greater access to medical cannabis for patients across the state.

  2. Licensee Limitations:

    • A single licensee may hold a maximum of three medical cannabidiol dispensary licenses. This provision aims to prevent monopolization and ensure a diverse range of dispensaries.

  3. Removal of Supply Requirement:

    • The bill strikes a provision from current law that required dispensaries to begin supplying medical cannabidiol by December 1, 2018. This change may provide dispensaries with more flexibility in their operational timelines.

  4. Annual Licensing Process:

    • The Department of Commerce is tasked with licensing new dispensaries or relicensing existing ones by December 1 of each year, ensuring a regular review and renewal process.

Impact

  • Patients: The bill is expected to benefit patients who rely on medical cannabidiol by increasing the number of dispensaries available to them, potentially leading to better access and variety of products.

  • Dispensary Operators: Current and prospective dispensary operators may find new opportunities for business as the number of licenses increases. The ability to hold multiple licenses may also encourage investment in the sector.

  • Regulatory Framework: The changes to the licensing process and requirements may streamline operations for the Department of Commerce, allowing for more efficient management of dispensary licenses.

Legislative Timeline

  • January 15, 2025: Bill introduced and referred to the Commerce Committee.
  • January 22, 2025: Subcommittee meeting held to discuss the bill.
  • January 23, 2025: Subcommittee recommends amendment and passage.
  • February 20, 2025: Committee report approving the bill, renumbered as SF 399.

This summary provides an overview of Bill SF 46, highlighting its intent, key provisions, and potential impacts on stakeholders involved in the medical cannabidiol industry.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.